Cefazolin and Phenytoin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Phenytoin (phenytoin). Common drug interactions include platelet count decreased among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Phenytoin. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Phenytoin?

Phenytoin has active ingredients of phenytoin. It is often used in epilepsy. eHealthMe is studying from 15,753 Phenytoin users. Check the latest studies of Phenytoin.



On Jul, 09, 2026

69 people who take Cefazolin and Phenytoin together, and have interactions are studied.

Cefazolin and Phenytoin drug interactions.

What are the common drug interactions of Cefazolin and Phenytoin, by gender? *:

female:

  1. Platelet count decreased
  2. Pyrexia (fever)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Abdominal discomfort
  5. Abdominal pain
  6. Activities of daily living impaired
  7. Altered state of consciousness (altered state of mind)
  8. Anaemia (lack of blood)
  9. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  10. Blood glucose decreased

male:

  1. Pyrexia (fever)
  2. Pneumonia
  3. Renal failure acute (rapid kidney dysfunction)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Conjunctivitis (pink eye)
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  7. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  8. Abdominal distension
  9. Abdominal pain
  10. Acidosis (build-up of carbon dioxide in the blood)

What are the common drug interactions of Cefazolin and Phenytoin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cerebral infarction (less blood supply to brain resulting tissue damage)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Haematemesis (vomiting of blood)

10-19:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
  3. Blood creatine phosphokinase increased
  4. Dermatitis medicamentosa (an irritation of the scrotum caused by an allergic reaction to a drug)
  5. Drug eruption (adverse drug reaction of the skin)
  6. Drug hypersensitivity
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  9. Erythema (redness of the skin)
  10. Hypoxic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)

20-29:

  1. Pneumonia
  2. Fall
  3. Pyrexia (fever)
  4. Cardiac arrest
  5. Diabetes insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function)
  6. Haemodynamic instability (disturbances in the blood movement in our body)
  7. Hypotension (abnormally low blood pressure)
  8. Activities of daily living impaired
  9. Altered state of consciousness (altered state of mind)
  10. Anaemia (lack of blood)

30-39:

  1. Abdominal distension
  2. Abdominal pain
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Anaemia (lack of blood)
  5. Anxiety
  6. Cardiac arrest
  7. Chest pain
  8. Collapse of lung (functional breakdown of lung)
  9. Constipation
  10. Cough

40-49:

  1. C-reactive protein increased
  2. Clavicle fracture
  3. Hypokalaemia (low potassium)
  4. Pneumonia
  5. Pruritus (severe itching of the skin)
  6. Rectal prolapse (falling of rectum from normal place)
  7. Altered state of consciousness (altered state of mind)
  8. Dry skin
  9. International normalised ratio increased
  10. Urine discolouration

50-59:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Eosinophil count increased
  3. Haematoma (collection of blood outside the blood vessels)
  4. Haematuria present (presence of blood in urine due to trauma)
  5. Hepatic steatosis (fatty liver disease)
  6. Hospitalisation
  7. International normalised ratio increased
  8. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  10. Oedema (fluid collection in tissue)

60+:

  1. Pyrexia (fever)
  2. Conjunctivitis (pink eye)
  3. General physical health deterioration (weak health status)
  4. Heart rate decreased
  5. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  6. Platelet count decreased
  7. Pneumonia
  8. Rash
  9. Renal failure (kidney dysfunction)
  10. Activated partial thromboplastin time prolonged

What are the existing conditions these people have? *

  1. Partial Seizures (seizures which affect only a part of the brain at onset): 8 people, 11.59%
  2. Paraneoplastic Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 8 people, 11.59%
  3. Peritonitis Bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial): 7 people, 10.14%
  4. Sedation: 6 people, 8.70%
  5. High Blood Pressure: 6 people, 8.70%
  6. Pain: 5 people, 7.25%
  7. Cardiac Disorder: 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and Phenytoin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin and Phenytoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenytoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenytoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and phenytoin (the active ingredients of Cefazolin and Phenytoin, respectively), and Cefazolin and Phenytoin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: